Role of nitric oxide in anticonvulsant effects of benzodiazepines in mice

Polish Journal of Pharmacology

Volumn 55, Issue 2, 2003, Pages 181-191

  Talarek, Sylwia ^a   Fidecka, Sylwia ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Benzodiazepines; Mice; Nitric oxide; Seizures

Indexed keywords

7 NITROINDAZOLE; ARGININE; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; CYCLIC GMP; DEXTRO ARGININE; DIAZEPAM; GUANYLATE CYCLASE INHIBITOR; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CLONIC SEIZURE; CONTROLLED STUDY; DEATH; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; ELECTRIC SHOCK; MALE; MOUSE; NONHUMAN; SEIZURE; TONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; ARGININE; CLONAZEPAM; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTROSHOCK; GUANYLATE CYCLASE; INDAZOLES; MALE; METHYLENE BLUE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTYLENETETRAZOLE; SEIZURES;

EID: 0038237442     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. G-nitro-L-arginine methyl ester interferes with pentylenetetrazole-induced kindling and has no effect on changes in glutamate binding. Brain Res., 1995, 688, 230-232.
2. Borowicz K.K., Kleinrok Z., Czuczwar S.: Influence of 7-nitroindazole on the anticonvulsive action of conventional antiepileptic drugs. Eur. J. Pharmacol., 1997, 331, 127-132.
3. Borowicz K.K., Łuszczki J., Kleinrok Z., Czuczwar S.J.: 7-Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazole-induced convulsions. J. Neural Transm., 2000, 107, 1117-1126.
4. G-nitroarginine methyl ester, an inhibitor of nitric oxide synthase, upon the anticonvulsive activity of conventional antiepileptic drugs against maximal electroshock in mice. J. Neural Transm., 1998, 105, 1-12.
5. Buisson A., Lakhmeche N., Verrecchie C., Plotkine M., Bonlu R.G.: Nitric oxide: an endogenous anticonvulsant substance. NeuroReport, 1993, 4, 444-446.
6. G-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res., 1993, 72, 387-395.
7. Czuczwar S.J., Turski W.A., Kleinrok Z.: Excitatory amino acid antagonists and the anticonvulsant action of conventional antiepileptic drugs. Metab. Brain Dis., 1996, 11, 143-152.
8. G-nitro-L-arginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazole. Eur. J. Pharmacol., 1999, 366, 137-142.
9. Dawson T.M., Snyder S.H.: Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci., 1994, 14, 5147-5159.
10. Del-Bel E.A., Oliveira P.R., Mishra P.K., Jobe P.C., Garcia-Cairasco N.: Anticonvulsant and proconvulsant roles of nitric oxide in experimental epilepsy models. Braz. J. Med. Biol. Res., 1997, 30, 971-979.
11. De Sarro G.B., Donato-Di-Paola E., De Sarro A., Vidal M.J.: Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepirioform cortex. Fundam. Clin. Pharmacol., 1991, 5, 503-511.
12. Deutsch S.I., Rosse R.B., Mom C., Koetzner L., Mastropaolo J.: Interference with nitric oxide production and action potentiates the antiseizure efficacy of flurazepam. Pharmacol. Biochem. Behav., 1995, 51, 133-137.
13. Dingledine R., McBain C.J., McNamara J.O.: Excitatory amino acid receptors in epilepsy. Trends Pharmacol. Sci., 1990, 11, 334-338.
14. G-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions. Eur. J. Pharmacol., 1996, 299, 9-16.
15. Fevell J.E., Johnson P.: Acute increases in blood pressure cause arousal from sleep in lambs. Brain Res., 1994, 311, 259-265.
16. A receptor. NeuroReport, 1998, 9, 1089-1093.
17. Getting S.J., Segieth J., Ahmad S., Biggs C.S., Whitton P.S.: Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo. Brain Res., 1996, 717, 1-2.
18. Guevara-Guzman R., Emson C.P., Kendrick K.M.: Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem., 1994, 62, 807-810.
19. Hobbs W.R., Rail T.W., Verdoorn R.A.: Hypnotics and sedatives: ethanol. In: Goodman and Gillman's The Pharmacological Basis of Therapeutics. Eds. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., McGraw-Hill, New York, 1996, 361-396.
20. Lalewicz S., Poleszak E., Fidecka S.: Participation of nitric oxide in the benzodiazepine withdrawal syndrome in mice and rats. Pol. J. Pharmacol., 1997, 49, 154.
21. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S.V., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S.: A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitro compounds. Nature, 1993, 346, 626-632.
22. Lonart G., Wang J., Johnson K.M.: Nitric oxide induces neurotransmitter release from hippocampal slices. Eur. J. Pharmacol., 1992, 220, 271-272.
23. Löscher W., Schmidt D.: Diazepam increases aminobutyric acid in human cerebrospinal fluid. J. Neurochem., 1987, 49, 152-157.
24. McLean M.J., Macdonald R.L.: Benzodiazepines, but not beta carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture. J. Pharmacol. Exp. Ther., 1988, 244, 789-795.
25. Meller S.T., Gebhart G.F.: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain, 1993, 52, 127-136.
26. Möller H., Fritschy J.M., Rudolph U.: A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther., 2002, 300, 2-8.
27. 3H]aminobutyric acid release from striatal slices. Neurosci. Lett., 1995, 190, 195-198.
28. Moncada S., Palmer R.M.I., Higgs E.A.: Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol. Rev., 1991, 43, 109-142.
29. Moore P.K., Wallace P., Gaffen Z., Hart S.L., Babbedge R.C.: Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Brit. J. Pharmacol., 1993, 110, 218-224.
30. Mülsch A., Busse R., Mordvintcev P.I., Vanin A.F., Nielsen E.O., Scheel-Krüger J., Olsen S.P.: Nitric oxide promotes seizure activity in kainate-treated rats. NeuroReport, 1994, 5, 2325-2328.
31. Osonoe K., Mori N., Suzuki K., Osonoe M.: Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazole-induced seizures in rats. Brain Res., 1994, 663, 338-340.
32. Penix L.P., Davis W., Subramaniam S.: Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res., 1994, 18, 177-184.
33. Przegaliński E., Baran L., Siwanowicz J.: The role of nitric oxide in the kainate-induced seizures in mice. Neurosci. Lett., 1994, 170, 74-76.
34. Przegaliński E., Baran L., Siwanowicz J.: The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci. Lett., 1996, 217, 145-148.
35. Quock R.M., Nguyen E.: Possible involvement of nitric oxide in chlordiazepoxide-induced anxiolysis in mice. Life Sci., 1992, 51, 255-260.
36. Rees D.D., Palmer R.M.J., Schultz R., Hodson H.F. Moncada S.: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Brit. J. Pharmacol., 1990, 101, 746-752.
37. Rho J.M., Sankar R.: The pharmacologic basis of antiepileptic drug action. Epilepsia, 1999, 40, 1471-1483.
38. Robello M., Amico C., Cupello A.: A dual mechanism for impairment of GABAA receptor activity by NMDA receptor activation in rat cerebellum granule cells. Eur. Biophys. J., 1997, 25, 181-187.
39. Rondouin G., Bockaert I., Lerner-Natoli M.: L-Nitro-arginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. NeuroReport, 1993, 4, 1187-1190.
40. Salter M., Duffy C., Hazelwood R.: Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results. Neuropharmacology, 1995, 34, 327-334.
41. Segovia G., Porras A., Mora F.: Effects of a nitric oxide donor on glutamate and GABA release in striatum. and hippocampus of the conscious rat. NeuroReport, 1994, 5, 1937-1940.
42. Skerritt J.H., Werz M.A., McLean M.J., Macdonald R.L: Diazepam and its anomalous p-chloro-derivative Ro 5-4864: comparative effects on mouse neurons in cell culture. Brain Res., 1984, 310, 99-105.
43. Snyder S.H., Bredt D.S.: Nitric oxide as a neural messenger. Trends Pharmacol. Sci., 1991, 12, 125-128.
44. Swinyard E.A., Castellion A.W.: Anticonvulsant properties of some benzodiazepines. J. Pharmacol. Exp. Ther., 1966, 151, 369-375.
45. Talarek S., Fidecka S.: Nitric oxide (NO) and antiepileptic activity of benzodiazepines in mice. Pol. J. Pharmacol., 1998, 50, 177-178.
46. Talarek S., Fidecka S.: Role of nitric oxide in benzodiazepines-induced antinociception in mice. Pol. J. Pharmacol., 2002, 54, 27-34.
47. Theard M.A., Baughman V.L., Wang Q., Pelligrino D.A., Albrecht R.F.: The role of nitric oxide in modulating brain activity and blood flow during seizure. NeuroReport, 1995, 6, 921-924.
48. G-Nitro-L-arginine differentially affects glutamate- or kainate-induced seizures. NeuroReport, 1996, 7, 1605-1608.
49. Tutka P., Łuszczki J., Kleinrok Z., Arent K., Wielosz M.: Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice. J. Neural Transm., 2002, 109, 45 5-466.
50. Valthschanoff J.G., Weinberg R.J., Kharazia V.N., Schmidt H.H.H.W., Nakane M., Rustioni A.: Neurons in rat cerebral cortex that synthesize nitric oxide: NADPH diaphorase histochemistry, NOS inummocytochemistry, and colocalization with GABA. Neurosci. Lett., 1993, 157, 157-161.
51. Vogel H.G., Vogel W.H.: Drug Discovery and Evaluation of Pharmacological Assays. Springer-Verlag, Berlin, Heidelberg, 1997.
52. A receptors. Neurosci. Lett., 1994, 180, 239-242.